Shares of Teleflex Inc. TFX advanced 1.05% to $137.71 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 2.13% to 5,638.94 and ...

Teleflex's (NYSE: TFX) fourth-quarter 2024 earnings conference call, held on February 27, 2025, revealed significant ...

Teleflex, whose shares sank nearly 20% Thursday, will acquire most of Biotronik’s vascular intervention assets. Teleflex also announced a CFO transition.

Medical technology company Teleflex (NYSE:TFX) in Q4 CY2024 as sales rose 2.8% year on year to $795.4 million. Its non-GAAP profit of $3.89 per share was in line with analysts’ consensus estimates. Is ...

NEW YORK, NY / ACCESS Newswire / March 12, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Teleflex ...

Teleflex is splitting its business into two independently traded entities, with a completion date set for mid-2026 ...

Teleflex plans to split into two companies by mid-2026, with RemainCo focusing on high-growth hospital markets and NewCo on urology and OEM. Teleflex will acquire Biotronik's Vascular Intervention ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $158.75, ...

Teleflex to create a new, independent publicly traded company ("NewCo”) consisting of Teleflex's Urology, Acute Care, and OEM businesses. Teleflex RemainCo ("RemainCo”) will consist of Teleflex's ...

Teleflex's management announced a significant acquisition and business split, but the market reacted negatively, dropping the shares over 20%. Fourth quarter earnings and 2025 guidance show weak ...

Most recently, AcuityMD signed Teleflex Incorporated, a global provider of medical technologies that offers solutions across therapy areas, including interventional urology. Teleflex leverages ...

Teleflex is separating into two publicly traded companies to optimize growth and shareholder value. The acquisition of Biotronik's Vascular Intervention expands Teleflex's presence in coronary and ...